EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Curaleaf Holdings's Enterprise Value is $3,586 Mil.
Curaleaf Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $55 Mil. Therefore, Curaleaf Holdings's EV-to-FCF for today is 65.36.
The historical rank and industry rank for Curaleaf Holdings's EV-to-FCF or its related term are showing as below:
CURLD'
s EV-to-FCF Range Over the Past 10 Years
Min: -588.62 Med: -25.25 Max: 1027.59
Current: 65.36
During the past 12 years, the highest EV-to-FCF of Curaleaf Holdings was 1027.59. The lowest was -588.62. And the median was -25.25.
CURLD's EV-to-FCF is ranked worse than 79.82% of 560
companies
in the Drug Manufacturers industry
Industry Median: 20.52
vs CURLD: 65.36
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Curaleaf Holdings's PE Ratio (TTM) for today is calculated as:
Curaleaf Holdings's share price for today is $10.52.
Curaleaf Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.607.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Curaleaf Holdings EV-to-FCF Related Terms
Curaleaf Holdings EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Curaleaf Holdings's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Curaleaf Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Curaleaf Holdings EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Curaleaf Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Curaleaf Holdings's EV-to-FCF falls into.
Curaleaf Holdings's current Enterprise Value is $3,586 Mil.
Curaleaf Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $55 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Curaleaf Holdings (CURLD) has a EV-to-FCF of 65.36 as of Jul. 01, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Curaleaf Holdings and its competitors. According to the industry distribution chart, Curaleaf Holdings ranks #447 out of 560 companies in the Drug Manufacturers industry, placing it in the top 79.8%.
Is Curaleaf Holdings' EV-to-FCF too high?
Curaleaf Holdings' current EV-to-FCF is 65.36. The Drug Manufacturers industry median EV-to-FCF is 20.52. Curaleaf Holdings' value of 65.36 is 218.5% above this industry median. Based on the distribution chart, Curaleaf Holdings ranks #447 out of 560 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Curaleaf Holdings has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Curaleaf Holdings' EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Curaleaf Holdings ranks #447 out of 560 companies for EV-to-FCF. This places Curaleaf Holdings in the lower half of its industry. The industry median EV-to-FCF is 20.52. Curaleaf Holdings' value of 65.36 is 218.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.52, based on 560 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Curaleaf Holdings's current EV-to-FCF of 65.36 is 218.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Curaleaf Holdings and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Curaleaf Holdings's current EV-to-FCF is 65.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curaleaf Holdings stock overvalued right now?
Based on GuruFocus' analysis, Curaleaf Holdings (CURLD) is currently considered Significantly Overvalued. The stock's GF Value™ is $8.04, compared to a current price of $10.52 — trading 30.8% above its estimated fair value. The current EV-to-FCF is 65.36 and 218.5% above the Drug Manufacturers industry median of 20.52. Curaleaf Holdings' overall GF Score™ is 66/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Curaleaf Holdings (CURLD), the current EV-to-FCF is 65.36 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Curaleaf Holdings (CURLD) Overvalued in 2026?
Based on GuruFocus' analysis, Curaleaf Holdings stock appears to be overvalued.
The current stock price of $10.52 is trading 30.8% above its estimated GF Value™ of $8.04.
GuruFocus considers Curaleaf Holdings to be Significantly Overvalued.
Key valuation signals for CURLD:
EV-to-FCF: 65.36
GF Value™: $8.04 vs. price of $10.52 (30.8% above fair value)
Industry Position: 218.5% above the Drug Manufacturers median (#447 of 560)
No single metric tells the full story. See the CURLD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
66GF Score
Get the complete analysis for CURLD
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CURLD has been successfully added to your 
